Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in mammalian cells
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
From 21 September 2012 to 22 January 2013
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Study conducted in accordance with validated testing guidelines and under GLP conditions.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2013
Report date:
2013

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
mammalian cell gene mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Bis(4-(1,1,3,3-tetramethylbutyl)phenyl)amine
EC Number:
239-816-9
EC Name:
Bis(4-(1,1,3,3-tetramethylbutyl)phenyl)amine
Cas Number:
15721-78-5
Molecular formula:
C28H43N
IUPAC Name:
4-(2,4,4-trimethylpentan-2-yl)-N-[4-(2,4,4-trimethylpentan-2-yl)phenyl]aniline
Test material form:
solid: particulate/powder
Remarks:
migrated information: powder
Details on test material:
Batch number: HY12HSV09
Purity: >93%

Method

Species / strain
Species / strain / cell type:
mouse lymphoma L5178Y cells
Metabolic activation:
with and without
Metabolic activation system:
S9 mix
Test concentrations with justification for top dose:
Experiment 1: 15.63, 31.25, 62.5, 125, 250, 500 μg/mL
Experiment 2: 15.63, 31.25, 62.5, 125, 250, 500 μg/mL
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: acetone

No additional data
Controlsopen allclose all
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
ethylmethanesulphonate
Remarks:
Experiment 1 (-S9) 4-Hour Exposure; Experiment 2 (-S9) 24-Hour Exposure
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
cyclophosphamide
Remarks:
Experiment 1 (+S9) 4-Hour Exposure
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium

DURATION
- Exposure duration: In Experiment 1, 4-hour exposure; In Experiment 2, 4-hour exposure and 24-hour exposure

NUMBER OF REPLICATIONS: 2

OTHER EXAMINATIONS:
- Other: The daily cell counts were used to obtain a Relative Suspension Growth (%RSG) value that gives an indication of post treatment toxicity during the expression period as a comparison to the vehicle control, and when combined with the Viability (%V) data a Relative Total Growth (RTG) value.

No additional data
Evaluation criteria:
Vehicle controls results should ideally be within this range, although minor errors in cell counting and dilution or exposure to the metabolic activation system may cause this to be slightly elevated. Experiments where the vehicle control values are markedly greater than 2E-04 mutant frequency per survivor are
not normally acceptable and will be repeated.

Positive control chemicals should induce at least three to five fold increases in mutant frequency greater than the corresponding vehicle control.
Statistics:
None stated

Results and discussion

Test results
Species / strain:
mouse lymphoma L5178Y cells
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not valid
Positive controls validity:
valid
Additional information on results:
With no evidence of significant toxicity in the preliminary toxicity test, the maximum dose level used in the Mutagenicity Test was limited by the onset of greasy/oily precipitate that was considered to be effectively reducing exposure of Bis(4‐(1,1,3,3‐tetramethylbutyl)phenyl)amine to the cells.

In the Mutagenicity Test, precipitate of Bis(4‐(1,1,3,3‐tetramethylbutyl)phenyl)amine was observed at and above 31.25 μg/mL and became greasy/oily in appearance at 500 μg/mL. The vehicle (solvent) controls had mutant frequency values that were considered acceptable for the L5178Y cell line at the TK +/- locus.

The positive control items induced marked increases in the mutant frequency indicating the satisfactory performance of the test and of the activity of the metabolising system.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

Bis(4‐(1,1,3,3‐tetramethylbutyl)phenyl)amine did not induce any toxicologically significant increases in the mutant frequency at the TK +/- locus in L5178Y cells and is therefore considered to be non-mutagenic under the conditions of the test.